Harvest Investment Services, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Harvest Investment Services, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 29, 2021	SELL	$574.03 - $680.96 $3.31 Million - $3.92 Million	-5,759 Closed	0 $0
Q2 2021 Aug 10, 2021	SELL	$472.8 - $558.54 $176,827 - $208,893	-374 Reduced 6.1%	5,759 $3.22 Million
Q1 2021 May 06, 2021	BUY	$446.73 - $548.2 $17,422 - $21,379	39 Added 0.64%	6,133 $2.9 Million
Q4 2020 Feb 01, 2021	BUY	$478.3 - $607.98 $1.25 Million - $1.59 Million	2,607 Added 74.76%	6,094 $2.94 Million
Q3 2020 Oct 29, 2020	BUY	$544.75 - $658.21 $1.23 Million - $1.48 Million	2,253 Added 182.58%	3,487 $1.95 Million

Q2 2020 Aug 11, 2020	SELL	$493.32 - $643.92 $224,460 - $292,983	-455 Reduced 26.94%	1,234 $769,000
Q1 2020 Apr 21, 2020	BUY	$336.18 - $494.43 $567,808 - $835,092	1,689 New	1,689 $824,000

1,427

82.1M

835K

1.46M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $111B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Harvest Investment Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Harvest Investment Services, LLC with notifications on news.